Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy: Melanoma brain metastases prognostic score

BACKGROUND: Melanoma patients frequently develop brain metastases. The most widely used score to predict survival is the molGPA based on a mixed treatment of stereotactic radiotherapy (SRT) and whole brain radiotherapy (WBRT). In addition, systemic therapy was not considered. We therefore aimed to e...

Descripción completa

Detalles Bibliográficos
Autores principales: Schaule, Jana, Kroeze, Stephanie G. C., Blanck, Oliver, Stera, Susanne, Kahl, Klaus H., Roeder, Falk, Combs, Stephanie E., Kaul, David, Claes, An, Schymalla, Markus M., Adebahr, Sonja, Eckert, Franziska, Lohaus, Fabian, Abbasi-Senger, Nasrin, Henke, Guido, Szuecs, Marcella, Geier, Michael, Sundahl, Nora, Buergy, Daniel, Dummer, Reinhard, Guckenberger, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268472/
https://www.ncbi.nlm.nih.gov/pubmed/32487100
http://dx.doi.org/10.1186/s13014-020-01558-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268472/
https://www.ncbi.nlm.nih.gov/pubmed/32487100
http://dx.doi.org/10.1186/s13014-020-01558-8

Ejemplares similares